thor life sciences ltd Company Information
Company Number
09640667
Website
www.thor-companies.comRegistered Address
70 south lambeth road, ground floor, london, SW8 1RL
Industry
Activities of employment placement agencies (other than motion picture, television and other theatrical casting) n.e.c.
Telephone
442034758431
Next Accounts Due
February 2025
Group Structure
View All
Shareholders
thor companies investments ltd 100%
thor life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of THOR LIFE SCIENCES LTD at £4.1k based on a Turnover of £24k and 0.17x industry multiple (adjusted for size and gross margin).
thor life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of THOR LIFE SCIENCES LTD at £231.1k based on an EBITDA of £76.6k and a 3.02x industry multiple (adjusted for size and gross margin).
thor life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of THOR LIFE SCIENCES LTD at £1.9m based on Net Assets of £1.1m and 1.72x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Thor Life Sciences Ltd Overview
Thor Life Sciences Ltd is a live company located in london, SW8 1RL with a Companies House number of 09640667. It operates in the other activities of employment placement agencies sector, SIC Code 78109. Founded in June 2015, it's largest shareholder is thor companies investments ltd with a 100% stake. Thor Life Sciences Ltd is a young, micro sized company, Pomanda has estimated its turnover at £24k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Thor Life Sciences Ltd Health Check
Pomanda's financial health check has awarded Thor Life Sciences Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £24k, make it smaller than the average company (£6.6m)
- Thor Life Sciences Ltd
£6.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -79%, show it is growing at a slower rate (4.3%)
- Thor Life Sciences Ltd
4.3% - Industry AVG
Production
with a gross margin of 25.2%, this company has a comparable cost of product (25.2%)
- Thor Life Sciences Ltd
25.2% - Industry AVG
Profitability
an operating margin of 319.1% make it more profitable than the average company (4.5%)
- Thor Life Sciences Ltd
4.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (35)
- Thor Life Sciences Ltd
35 - Industry AVG
Pay Structure
on an average salary of £49.2k, the company has an equivalent pay structure (£49.2k)
- Thor Life Sciences Ltd
£49.2k - Industry AVG
Efficiency
resulting in sales per employee of £24k, this is less efficient (£170.7k)
- Thor Life Sciences Ltd
£170.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Thor Life Sciences Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 16 days, this is slower than average (9 days)
- Thor Life Sciences Ltd
9 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Thor Life Sciences Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)
0 weeks - Thor Life Sciences Ltd
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.1%, this is a lower level of debt than the average (66.6%)
1.1% - Thor Life Sciences Ltd
66.6% - Industry AVG
THOR LIFE SCIENCES LTD financials
Thor Life Sciences Ltd's latest turnover from May 2023 is estimated at £24 thousand and the company has net assets of £1.1 million. According to their latest financial statements, we estimate that Thor Life Sciences Ltd has 1 employee and maintains cash reserves of £69 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | |
---|---|---|---|---|---|---|---|---|
Turnover | ||||||||
Other Income Or Grants | ||||||||
Cost Of Sales | ||||||||
Gross Profit | ||||||||
Admin Expenses | ||||||||
Operating Profit | ||||||||
Interest Payable | ||||||||
Interest Receivable | ||||||||
Pre-Tax Profit | ||||||||
Tax | ||||||||
Profit After Tax | ||||||||
Dividends Paid | ||||||||
Retained Profit | ||||||||
Employee Costs | ||||||||
Number Of Employees | 8 | 6 | 5 | 6 | 4 | 5 | ||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | |
---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 2,279 | 2,279 | 2,279 | 536 | 603 | 0 | 0 | 0 |
Investments & Other | 821 | 821 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 4,695 | 4,695 | 821 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 7,795 | 7,795 | 3,100 | 536 | 603 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 519,296 | 236,005 | 175,478 | 12,227 | 59,335 | 217,319 | 21,642 |
Group Debtors | 550,574 | 991,102 | 825,922 | 331,765 | 663,649 | 343,501 | 153,990 | 0 |
Misc Debtors | 539,837 | 19,288 | 288,728 | 42,625 | 50,211 | 19,598 | 24,689 | 18,875 |
Cash | 69 | 502,804 | 347,217 | 572,113 | 296,784 | 392,993 | 319,206 | 140,887 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,090,480 | 2,032,490 | 1,697,872 | 1,121,981 | 1,022,871 | 815,427 | 715,204 | 181,404 |
total assets | 1,098,275 | 2,040,285 | 1,700,972 | 1,122,517 | 1,023,474 | 815,427 | 715,204 | 181,404 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 795 | 279,487 | 210,510 | 240,950 | 64,926 | 43,133 | 52,365 | 2,334 |
Group/Directors Accounts | 0 | 365,798 | 224,102 | 313,819 | 517,490 | 431,048 | 451,371 | 178,910 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 11,030 | 356,167 | 401,458 | 112,401 | 71,433 | 59,725 | 67,512 | 150 |
total current liabilities | 11,825 | 1,001,452 | 836,070 | 667,170 | 653,849 | 533,906 | 571,248 | 181,394 |
loans | 0 | 0 | 100,000 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 18,289 | 18,289 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 18,289 | 118,289 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 11,825 | 1,019,741 | 954,359 | 667,170 | 653,849 | 533,906 | 571,248 | 181,394 |
net assets | 1,086,450 | 1,020,544 | 746,613 | 455,347 | 369,625 | 281,521 | 143,956 | 10 |
total shareholders funds | 1,086,450 | 1,020,544 | 746,613 | 455,347 | 369,625 | 281,521 | 143,956 | 10 |
May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | |
---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Operating Profit | ||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 113 | 67 | 67 | 0 | 0 | 0 |
Tax | ||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -439,275 | 182,905 | 801,608 | -176,219 | 303,653 | 26,436 | 355,481 | 40,517 |
Creditors | -278,692 | 68,977 | -30,440 | 176,024 | 21,793 | -9,232 | 50,031 | 2,334 |
Accruals and Deferred Income | -345,137 | -45,291 | 289,057 | 40,968 | 11,708 | -7,787 | 67,362 | 150 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||
Investing Activities | ||||||||
capital expenditure | ||||||||
Change in Investments | 0 | 821 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||
Financing Activities | ||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -365,798 | 141,696 | -89,717 | -203,671 | 86,442 | -20,323 | 272,461 | 178,910 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -100,000 | 100,000 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -18,289 | 0 | 18,289 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||
interest | ||||||||
cash flow from financing | ||||||||
cash and cash equivalents | ||||||||
cash | -502,735 | 155,587 | -224,896 | 275,329 | -96,209 | 73,787 | 178,319 | 140,887 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -502,735 | 155,587 | -224,896 | 275,329 | -96,209 | 73,787 | 178,319 | 140,887 |
thor life sciences ltd Credit Report and Business Information
Thor Life Sciences Ltd Competitor Analysis
Perform a competitor analysis for thor life sciences ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in SW8 area or any other competitors across 12 key performance metrics.
thor life sciences ltd Ownership
THOR LIFE SCIENCES LTD group structure
Thor Life Sciences Ltd has no subsidiary companies.
Ultimate parent company
1 parent
THOR LIFE SCIENCES LTD
09640667
thor life sciences ltd directors
Thor Life Sciences Ltd currently has 3 directors. The longest serving directors include Mr Nicholas Sym (Jun 2015) and Mr Christopher Singleton (Jul 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Nicholas Sym | England | 38 years | Jun 2015 | - | Director |
Mr Christopher Singleton | England | 38 years | Jul 2015 | - | Director |
Mr James Gorman | United Kingdom | 37 years | Jul 2015 | - | Director |
P&L
May 2023turnover
24k
-99%
operating profit
76.6k
0%
gross margin
25.3%
-3.23%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
1.1m
+0.06%
total assets
1.1m
-0.46%
cash
69
-1%
net assets
Total assets minus all liabilities
thor life sciences ltd company details
company number
09640667
Type
Private limited with Share Capital
industry
78109 - Activities of employment placement agencies (other than motion picture, television and other theatrical casting) n.e.c.
incorporation date
June 2015
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2023
previous names
thor companies limited (June 2016)
accountant
TC GROUP
auditor
-
address
70 south lambeth road, ground floor, london, SW8 1RL
Bank
-
Legal Advisor
-
thor life sciences ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to thor life sciences ltd.
thor life sciences ltd Companies House Filings - See Documents
date | description | view/download |
---|